KRTL Holding Group

KRTL Holding Group (OTC: KRTL) drives innovation, compliance, and market connectivity through the specialized expertise of its subsidiaries. The group maintains a competitive edge in the marketplace by pursuing mergers, acquisitions, collaborations, and strategic alliances with select partners. KRTL Biotech Is a registered FDA pharmaceutical company, while KRTL International Inc ensures these innovations reach the right markets with precision and strategic consulting.

company name

Offering Type:
Dual Listing

Asset Type:
Common Stock (Equity)

Upstream Ticker Symbol:
KRTL

Important: U.S. investors may not deposit, buy, or sell securities Upstream.

Visit the Support Center for help on Upstream.

KRTL Holding Group (OTC: KRTL) serves as the parent company, providing strategic oversight and ensuring synergy among its subsidiaries. The group’s mission is to integrate innovation, regulatory excellence, and market expertise to deliver comprehensive solutions and drive sustainable growth.

KRTL Biotech Inc.

KRTL Biotech Inc, a wholly owned subsidiary of KRTL Holding Group (OTC: KRTL) and an FDA-registered pharmaceutical company, is dedicated to advancing biotechnology research and development. The company partners with cGMP manufacturers, ISO-certified laboratories, and academic institutions to foster innovation and deliver solutions across various sectors. Its commitment to quality and compliance makes it the foundation of KRTL’s operations and a leader in cutting-edge biotechnology.

KRTL International Inc.

KRTL International Inc, a wholly owned subsidiary of KRTL Holding Group (OTC: KRTL), is the distribution and consulting arm of the group. It bridges the gap between innovation and global markets by providing expert consulting services, strategic market analysis, and efficient distribution systems. This subsidiary ensures that KRTL’s products and solutions are tailored to client needs and delivered seamlessly worldwide.

Collaboration: A Unified Force

Together, KRTL Holding Group (OTC: KRTL), KRTL Biotech Inc, and KRTL International Inc form a cohesive and powerful team:

  1. Leadership: KRTL Holding Group provides centralized strategy, aligning the subsidiaries to achieve shared goals.
  2. Innovation: KRTL Biotech Inc develops cutting-edge, FDA-compliant biotech solutions through strategic partnerships with industry leaders.
  3. Connection: KRTL International Inc ensures these innovations are distributed effectively and backed by consulting expertise.​

This unified approach enables KRTL Holding Group to deliver unmatched value, scale efficiently, and maintain a competitive edge in the biotechnology and consulting industries.

Website

News

Regulatory Filings

Stay Connected

FAQ

Important: U.S. investors may not deposit, buy, or sell securities Upstream. For more information, please visit the Upstream Support Center.

Important: U.S. investors may not deposit, buy, or sell securities Upstream. For more information, please visit the Upstream Support Center.

U.S. PERSONS MAY NOT DEPOSIT, BUY, OR SELL SECURITIES ON UPSTREAM. THE OFFER SHARES ARE ONLY SUITABLE FOR INVESTORS: (I) WHO UNDERSTAND THE POTENTIAL RISK OF CAPITAL LOSS AND THAT THERE MAY BE LIMITED LIQUIDITY IN THE UNDERLYING INVESTMENTS OF THE COMPANY; (II) FOR WHOM AN INVESTMENT IN THE OFFER SHARES IS PART OF A DIVERSIFIED INVESTMENT PROGRAM; AND (III) WHO FULLY UNDERSTAND AND ARE WILLING TO ASSUME THE RISKS INVOLVED IN SUCH AN INVESTMENT PROGRAM. IT SHOULD BE REMEMBERED THAT THE PRICE OF THE SHARES AND THE INCOME FROM THEM CAN GO DOWN AS WELL AS UP. THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION A CROWD FINANCED INITIAL PUBLIC OFFERING INVESTMENT INVOLVES RISK. YOU SHOULD NOT INVEST ANY FUNDS IN THIS OFFERING UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED OR APPROVED BY UPSTREAM, MERJ, HORIZON FINTEX ADVISORS, THE REPUBLIC OF SEYCHELLES OR ANY FEDERAL SECURITIES COMMISSION OR REGULATORY AUTHORITY OF ANY OTHER JURISDICTION. THE COMPANY URGES YOU TO CAREFULLY REVIEW THE PROSPECTUS, PARTICULARLY THE SECTION TITLED "RISK FACTORS" IN THE PROSPECTUS FOR A MORE COMPLETE DISCUSSION OF THE RISK OF AN INVESTMENT IN THE COMPANY. FURTHERMORE, THESE AUTHORITIES HAVE NOT PASSED UPON THE ACCURACY OR ADEQUACY OF THE PROSPECTUS OR COMPLETENESS OF ANY OFFERING DOCUMENT OR LITERATURE. THE WEBSITE AND PROSPECTUS CONTAINS FORWARD LOOKING STATEMENTS BASED ON ASSUMPTIONS AND REFLECTS THE DIRECTORS EXPECTATIONS, ESTIMATES AND PROJECTIONS OF FUTURE EVENTS. FORWARD LOOKING STATEMENTS INCLUDE WITHOUT LIMITATION, STATEMENTS REGARDING THE PERFORMANCE, PROSPECTS, OPPORTUNITIES, PRIORITIES, TARGETS, GOALS, OBJECTIVES, STRATEGIES, GROWTH AND OUTLOOK OF THE COMPANY. OFTEN, BUT NOT ALWAYS, FORWARD LOOKING STATEMENTS CAN BE IDENTIFIED BY THE USE OF WORDS SUCH AS "EXPECTS", "ANTICIPATES", "PLANS", "BELIEVES", "ESTIMATES", "SEEKS", "INTENDS", "TARGETS", "PROJECTS", "FORECASTS", OR VARIATIONS (INCLUDING NEGATIVE VARIATIONS) OF SUCH WORDS AND PHRASES, OR STATE THAT CERTAIN ACTIONS, EVENTS OR RESULTS "MAY", "COULD", "WOULD", "MIGHT" OR "WILL" BE TAKEN, OCCUR OR BE ACHIEVED. FORWARD LOOKING STATEMENTS ARE BASED UPON CERTAIN MATERIAL FACTORS AND ASSUMPTIONS THAT WERE APPLIED IN DRAWING A CONCLUSION OR MAKING A FORECAST OR PROJECTION, INCLUDING ASSUMPTIONS AND ANALYSES MADE BY THE DIRECTORS IN THE LIGHT OF THEIR EXPERIENCE AND PERCEPTION OF HISTORICAL TRENDS, CURRENT CONDITIONS AND EXPECTED FUTURE DEVELOPMENTS, AS WELL AS OTHER FACTORS THAT ARE BELIEVED TO BE APPROPRIATE IN THE CIRCUMSTANCES. ALSO, FORWARD LOOKING STATEMENTS INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES AND OTHER FACTORS THAT ARE BEYOND THE DIRECTORS CONTROL AND WHICH MAY CAUSE THE ACTUAL RESULTS, PERFORMANCE OR ACHIEVEMENT TO BE MATERIALLY DIFFERENT FROM ANY FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY SUCH FORWARD LOOKING STATEMENTS. SUCH MATERIAL FACTORS AND ASSUMPTIONS AND RISKS AND UNCERTAINTIES INCLUDE, AMONG OTHERS, THOSE WHICH ARE INCORPORATED INTO THE PROSPECTUS AND QUALIFY ANY AND ALL FORWARD-LOOKING STATEMENTS MADE IN THE PROSPECTUS.